Chun-Che Liao
Overview
Explore the profile of Chun-Che Liao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang C, Hsu H, Lee Y, Jan J, Chang S, Lin Y, et al.
Biochem Pharmacol
. 2025 Jan;
232:116753.
PMID: 39826268
No abstract available.
2.
Chang Y, Hsu M, Chen W, Wu M, Kong W, Lu M, et al.
JCI Insight
. 2024 May;
9(10).
PMID: 38775156
Since its emergence, SARS-CoV-2 has been continuously evolving, hampering the effectiveness of current vaccines against COVID-19. mAbs can be used to treat patients at risk of severe COVID-19. Thus, the...
3.
Yang C, Liao C, Hsu H, Liang J, Chang C, Ko H, et al.
J Biomed Sci
. 2023 Oct;
30(1):87.
PMID: 37828601
Background: Human angiotensin-converting enzyme 2 (hACE2) is the receptor mediating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. hACE2 expression is low in the lungs and is upregulated after SARS-CoV-2...
4.
Sun C, Chiu C, Wu P, Tsung S, Lee I, Hu C, et al.
Mol Ther
. 2023 Sep;
31(11):3322-3336.
PMID: 37689971
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in the emergence of new variants that are resistant to existing vaccines and therapeutic antibodies, has raised the...
5.
Yang C, Hsu H, Lee Y, Jan J, Chang S, Lin Y, et al.
Biochem Pharmacol
. 2023 Jul;
215():115688.
PMID: 37481137
Fucoidans are a class of long chain sulfated polysaccharides and have multiple biological functions. Herein, four natural fucoidans extracted from Fucus vesiculosus, F. serratus, Laminaria japonica and Undaria pinnatifida, were...
6.
Ko H, Li Y, Li Y, Chiang M, Lee Y, Liu W, et al.
Microbiol Spectr
. 2023 Apr;
11(3):e0464022.
PMID: 37097200
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a major public health threat globally, especially during the beginning of the pandemic in 2020....
7.
Huang Y, Hsu F, Wu J, Lin Y, Liu M, Yang C, et al.
J Microbiol Immunol Infect
. 2023 Mar;
56(3):506-515.
PMID: 36967265
Background: Understanding the neutralizing antibody (NAb) titer against COVID-19 over time is important to provide information for vaccine implementation. The longitudinal NAb titer over one year after SARS-CoV-2 infection is...
8.
Lee Y, Hsu H, Yang C, Lin Y, Chang S, Yang R, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36840037
In the original publication [...].
9.
Huang H, Wang S, Fang G, Chou W, Liao C, Sun C, et al.
J Med Virol
. 2023 Jan;
95(2):e28478.
PMID: 36609964
Patients with severe COVID-19 often suffer from lymphopenia, which is linked to T-cell sequestration, cytokine storm, and mortality. However, it remains largely unknown how severe acute respiratory syndrome coronavirus 2...
10.
Lee I, Lan Y, Wu P, Wu Y, Chen Y, Tseng S, et al.
Emerg Microbes Infect
. 2022 Nov;
12(1):2149353.
PMID: 36395071
Numerous vaccines have been developed to address the current COVID-19 pandemic, but safety, cross-neutralizing efficacy, and long-term protectivity of currently approved vaccines are still important issues. In this study, we...